A phase 1 study evaluating the safety, pharmacology and preliminary activity of MM-310 in patients with solid tumors.
2018
TPS2604Background: Ephrin receptor A2 (EphA2) is expressed in cancer and stroma cells in a wide range of solid tumors. MM-310 is an EphA2-targeting liposomal form of a docetaxel prodrug. Preclinica...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI